Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Ally Bridge Group

Status
ACTIVE
Global HQ
Hong Kong Island, China
Countries of investment
  • USA
  • China
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Biotechnology
  • Health Tech
  • AI
About
Ally Bridge Group is a global healthcare investment management firm focused on highimpact life science innovation. The firm was founded in 2013 by Frank Yu, who serves as Chief Executive Officer and Chief Investment Officer. It has managed over $6 billion in transactions across healthcare subsectors, with the mission to generate superior riskadjusted returns for investors while addressing unmet medical needs through the blend of scientific research and capital markets expertise. Ally Bridge Group operates from offices in New York and Hong Kong and invests in both private and public equity in the healthcare industry.
Min check size
$500K
Max check size
$2M
Fund size
NPS

Investment Thesis

Ally Bridge Group focuses on highimpact life science innovation, investing across the global healthcare industry to address unmet medical needs while generating superior riskadjusted returns.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Specializes in technology and healthcare investments across North America and Europe. With deep experience in late-stage venture and growth equity, the manager has successfully executed over 50 deals. Known for a data-driven approach that emphasizes sustainable scaling, they have achieved multiple high-value exits. Focused on fostering innovation while mitigating risks, their strategy has consistently delivered above-market returns.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp